<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36865559</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Macrophage: Key player in the pathogenesis of autoimmune diseases.</ArticleTitle><Pagination><StartPage>1080310</StartPage><MedlinePgn>1080310</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1080310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1080310</ELocationID><Abstract><AbstractText>The macrophage is an essential part of the innate immune system and also serves as the bridge between innate immunity and adaptive immune response. As the initiator and executor of the adaptive immune response, macrophage plays an important role in various physiological processes such as immune tolerance, fibrosis, inflammatory response, angiogenesis and phagocytosis of apoptotic cells. Consequently, macrophage dysfunction is a vital cause of the occurrence and development of autoimmune diseases. In this review, we mainly discuss the functions of macrophages in autoimmune diseases, especially in systemic lupus erythematosus (SLE), rheumatic arthritis (RA), systemic sclerosis (SSc) and type 1 diabetes (T1D), providing references for the treatment and prevention of autoimmune diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Yang, Zhao and Jia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dapartment of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dapartment of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Sujie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">macrophage</Keyword><Keyword MajorTopicYN="N">rheumatic arthritis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">systemic sclerosis</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>2</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36865559</ArticleId><ArticleId IdType="pmc">PMC9974150</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1080310</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Juarranz Y. Molecular and cellular basis of autoimmune diseases. Cells. (2021) 10(2):474. doi:&#xa0;10.3390/cells10020474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020474</ArticleId><ArticleId IdType="pmc">PMC7926515</ArticleId><ArticleId IdType="pubmed">33672111</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med (2001) 7(8):899&#x2013;905. doi:&#xa0;10.1038/90935</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/90935</ArticleId><ArticleId IdType="pubmed">11479621</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose NR. Prediction and prevention of autoimmune disease in the 21st century: A review and preview. Am J Epidemiol. (2016) 183(5):403&#x2013;6. doi:&#xa0;10.1093/aje/kwv292</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv292</ArticleId><ArticleId IdType="pubmed">26888748</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. (2005) 38(3):235&#x2013;45. doi:&#xa0;10.1080/08916930500050277</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500050277</ArticleId><ArticleId IdType="pubmed">16126512</ArticleId></ArticleIdList></Reference><Reference><Citation>Saferding V, Bl&#xfc;ml S. Innate immunity as the trigger of systemic autoimmune diseases. J Autoimmun (2020) 110:102382. doi:&#xa0;10.1016/j.jaut.2019.102382</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102382</ArticleId><ArticleId IdType="pubmed">31883831</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol (2009) 9(4):259&#x2013;70. doi:&#xa0;10.1038/nri2528</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2528</ArticleId><ArticleId IdType="pmc">PMC3648866</ArticleId><ArticleId IdType="pubmed">19282852</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. (2013) 496(7446):445&#x2013;55. doi:&#xa0;10.1038/nature12034</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12034</ArticleId><ArticleId IdType="pmc">PMC3725458</ArticleId><ArticleId IdType="pubmed">23619691</ArticleId></ArticleIdList></Reference><Reference><Citation>van FR, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, Langevoort HL. The mononuclear phagocyte system: A new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ (1972) 46(6):845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2480884</ArticleId><ArticleId IdType="pubmed">4538544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux F, Guilliams M. Tissue-resident macrophage ontogeny and homeostasis. Immunity. (2016) 44(3):439&#x2013;49. doi:&#xa0;10.1016/j.immuni.2016.02.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.024</ArticleId><ArticleId IdType="pubmed">26982352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 5(12):953&#x2013;64. doi:&#xa0;10.1038/nri1733</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1733</ArticleId><ArticleId IdType="pubmed">16322748</ArticleId></ArticleIdList></Reference><Reference><Citation>Den Haan JM, Kraal G. Innate immune functions of macrophage subpopulations in the spleen. J Innate Immun (2012) 4(5-6):437&#x2013;45. doi:&#xa0;10.1159/000335216</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000335216</ArticleId><ArticleId IdType="pmc">PMC6741446</ArticleId><ArticleId IdType="pubmed">22327291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, et al. . Adult langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med (2012) 209(6):1167&#x2013;81. doi:&#xa0;10.1084/jem.20120340</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20120340</ArticleId><ArticleId IdType="pmc">PMC3371735</ArticleId><ArticleId IdType="pubmed">22565823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. . Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. (2010) 330(6005):841&#x2013;5. doi:&#xa0;10.1126/science.1194637</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1194637</ArticleId><ArticleId IdType="pmc">PMC3719181</ArticleId><ArticleId IdType="pubmed">20966214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng J, Ruedl C, Karjalainen K. Most tissue-resident macrophages except microglia are derived from fetal hematopoietic stem cells. Immunity. (2015) 43(2):382&#x2013;93. doi:&#xa0;10.1016/j.immuni.2015.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.07.016</ArticleId><ArticleId IdType="pubmed">26287683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bain CC, Bravo-Blas A, Scott CL, Perdiguero EG, Geissmann F, Henri S, et al. . Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat Immunol (2014) 15(10):929&#x2013;37. doi: 10.1038/ni.2967</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2967</ArticleId><ArticleId IdType="pmc">PMC4169290</ArticleId><ArticleId IdType="pubmed">25151491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamoutounour S, Guilliams M, Montanana Sanchis F, Liu H, Terhorst D, Malosse C, et al. . Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity. (2013) 39(5):925&#x2013;38. doi:&#xa0;10.1016/j.immuni.2013.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.10.004</ArticleId><ArticleId IdType="pubmed">24184057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. (2016) 44(3):450&#x2013;62. doi:&#xa0;10.1016/j.immuni.2016.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.015</ArticleId><ArticleId IdType="pmc">PMC4794754</ArticleId><ArticleId IdType="pubmed">26982353</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon S, Pl&#xfc;ddemann A, Martinez Estrada F. Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev (2014) 262(1):36&#x2013;55. doi:&#xa0;10.1111/imr.12223</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12223</ArticleId><ArticleId IdType="pmc">PMC4231239</ArticleId><ArticleId IdType="pubmed">25319326</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MD, Silvin A, Ginhoux F, Merad M. Macrophages in health and disease. Cell. (2022) 185(23):4259&#x2013;79. doi:&#xa0;10.1016/j.cell.2022.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.10.007</ArticleId><ArticleId IdType="pmc">PMC9908006</ArticleId><ArticleId IdType="pubmed">36368305</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, et al. . Local macrophage proliferation in human glomerulonephritis. Kidney Int (1998) 54(1):143&#x2013;51. doi:&#xa0;10.1046/j.1523-1755.1998.00978.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1998.00978.x</ArticleId><ArticleId IdType="pubmed">9648072</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacke F. Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis In vivo. Fibrogenesis Tissue Repair (2012) 5(Suppl 1):S27. doi:&#xa0;10.1186/1755-1536-5-S1-S27</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-1536-5-S1-S27</ArticleId><ArticleId IdType="pmc">PMC3368797</ArticleId><ArticleId IdType="pubmed">23259611</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, et al. . Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut. (2012) 61(3):416&#x2013;26. doi:&#xa0;10.1136/gutjnl-2011-300304</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2011-300304</ArticleId><ArticleId IdType="pubmed">21813474</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescoat A, Lecureur V, Varga J. Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications. Curr Opin Rheumatol (2021) 33(6):463&#x2013;70. doi:&#xa0;10.1097/BOR.0000000000000835</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000835</ArticleId><ArticleId IdType="pubmed">34506339</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology (2000) 119(1):234&#x2013;42. doi:&#xa0;10.1053/gast.2000.8521</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/gast.2000.8521</ArticleId><ArticleId IdType="pubmed">10889174</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflammation Allergy (2005) 4(3):281&#x2013;6. doi:&#xa0;10.2174/1568010054022024</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568010054022024</ArticleId><ArticleId IdType="pubmed">16101534</ArticleId></ArticleIdList></Reference><Reference><Citation>Celhar T, Pereira-Lopes S, Thornhill SI, Lee HY, Dhillon MK, Poidinger M, et al. . TLR7 and TLR9 ligands regulate antigen presentation by macrophages. Int Immunol (2016) 28(5):223&#x2013;32. doi:&#xa0;10.1093/intimm/dxv066</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxv066</ArticleId><ArticleId IdType="pmc">PMC4888346</ArticleId><ArticleId IdType="pubmed">26567289</ArticleId></ArticleIdList></Reference><Reference><Citation>Frascaroli G, Lecher C, Varani S, Setz C, van der Merwe J, Brune W, et al. . Human macrophages escape inhibition of major histocompatibility complex-dependent antigen presentation by cytomegalovirus and drive proliferation and activation of memory CD4+ and CD8+ T cells. Front Immunol (2018) 9:1129. doi:&#xa0;10.3389/fimmu.2018.01129</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01129</ArticleId><ArticleId IdType="pmc">PMC5981096</ArticleId><ArticleId IdType="pubmed">29887865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yang L, Mao X, Li Z, Lin X, Jiang C. Streptococcus salivarius-mediated CD8+ T cell stimulation required antigen presentation by macrophages in oral squamous cell carcinoma. Exp Cell Res (2018) 366(2):121&#x2013;6. doi:&#xa0;10.1016/j.yexcr.2018.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.03.007</ArticleId><ArticleId IdType="pubmed">29530474</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulfig A, Bader V, Varatnitskaya M, Lupilov N, Winklhofer KF, Leichert LI. Hypochlorous acid-modified human serum albumin suppresses MHC class II - dependent antigen presentation in pro-inflammatory macrophages. Redox Biol (2021) 43:101981. doi:&#xa0;10.1016/j.redox.2021.101981</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.101981</ArticleId><ArticleId IdType="pmc">PMC8105673</ArticleId><ArticleId IdType="pubmed">33940547</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Shi XQ, Peyret C, Oladiran O, Wu S, Chambon J, et al. . Effector/memory CD8+ T cells synergize with co-stimulation competent macrophages to trigger autoimmune peripheral neuropathy. Brain Behav Immun (2018) 71:142&#x2013;57. doi:&#xa0;10.1016/j.bbi.2018.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.04.001</ArticleId><ArticleId IdType="pubmed">29627532</ArticleId></ArticleIdList></Reference><Reference><Citation>Panduro M, Benoist C, Mathis D. Treg cells limit IFN-&#x3b3; production to control macrophage accrual and phenotype during skeletal muscle regeneration. Proc Natl Acad Sci U S A. (2018) 115(11):E2585&#x2013;93. doi:&#xa0;10.1073/pnas.1800618115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800618115</ArticleId><ArticleId IdType="pmc">PMC5856564</ArticleId><ArticleId IdType="pubmed">29476012</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke EV, Weist BM, Walsh CM, Tenner AJ. Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol (2015) 97(1):147&#x2013;60. doi:&#xa0;10.1189/jlb.3A0614-278R</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3A0614-278R</ArticleId><ArticleId IdType="pmc">PMC4377823</ArticleId><ArticleId IdType="pubmed">25381385</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez J, Malireddi RK, Lu Q, Cunha LD, Pelletier S, Gingras S, et al. . Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat Cell Biol (2015) 17(7):893&#x2013;906. doi:&#xa0;10.1038/ncb3192</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3192</ArticleId><ArticleId IdType="pmc">PMC4612372</ArticleId><ArticleId IdType="pubmed">26098576</ArticleId></ArticleIdList></Reference><Reference><Citation>Boada-Romero E, Martinez J, Heckmann BL, Green DR. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol (2020) 21(7):398&#x2013;414. doi:&#xa0;10.1038/s41580-020-0232-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0232-1</ArticleId><ArticleId IdType="pmc">PMC7392086</ArticleId><ArticleId IdType="pubmed">32251387</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi C, Yanagihashi Y, Segawa K, Nagata S. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation. J Biol Chem (2019) 294(18):7221&#x2013;30. doi:&#xa0;10.1074/jbc.RA118.006628</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006628</ArticleId><ArticleId IdType="pmc">PMC6509494</ArticleId><ArticleId IdType="pubmed">30846565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano M, Nagata S. Efferocytosis and autoimmune disease. Int Immunol (2018) 30(12):551&#x2013;8. doi:&#xa0;10.1093/intimm/dxy055</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxy055</ArticleId><ArticleId IdType="pmc">PMC6234909</ArticleId><ArticleId IdType="pubmed">30165442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol (2008) 214(2):161&#x2013;78. doi:&#xa0;10.1002/path.2284</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2284</ArticleId><ArticleId IdType="pmc">PMC2724989</ArticleId><ArticleId IdType="pubmed">18161744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuda CM, Pope RM, Perlman H. The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases. Nat Rev Rheumatol (2016) 12(9):543&#x2013;58. doi:&#xa0;10.1038/nrrheum.2016.132</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.132</ArticleId><ArticleId IdType="pmc">PMC5297631</ArticleId><ArticleId IdType="pubmed">27549026</ArticleId></ArticleIdList></Reference><Reference><Citation>Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol (2016) 12(8):472&#x2013;85. doi:&#xa0;10.1038/nrrheum.2016.91</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.91</ArticleId><ArticleId IdType="pubmed">27383913</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Jiang JX, Zhang GX. Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett (2014) 160(1):17&#x2013;22. doi:&#xa0;10.1016/j.imlet.2014.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2014.03.006</ArticleId><ArticleId IdType="pmc">PMC6186449</ArticleId><ArticleId IdType="pubmed">24698730</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest. (2004) 114(5):623&#x2013;33. doi:&#xa0;10.1172/JCI22087</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI22087</ArticleId><ArticleId IdType="pmc">PMC514591</ArticleId><ArticleId IdType="pubmed">15343380</ArticleId></ArticleIdList></Reference><Reference><Citation>Aurora AB, Porrello ER, Tan W, Mahmoud AI, Hill JA, Bassel-Duby R, et al. . Macrophages are required for neonatal heart regeneration. J Clin Invest. (2014) 124(3):1382&#x2013;92. doi:&#xa0;10.1172/JCI72181</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72181</ArticleId><ArticleId IdType="pmc">PMC3938260</ArticleId><ArticleId IdType="pubmed">24569380</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan C, Xiao Y, Li K, Wang T, Liang Y, Liao G. MMP-12 regulates proliferation of mouse macrophages via&#x2002;the ERK/P38&#x2002;MAPK&#x2002;pathways during inflammation. Exp Cell Res (2019) 378(2):182&#x2013;90. doi:&#xa0;10.1016/j.yexcr.2019.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.03.018</ArticleId><ArticleId IdType="pubmed">30880028</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. (2017) 389(10086):2328&#x2013;37. doi:&#xa0;10.1016/S0140-6736(17)31472-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31472-1</ArticleId><ArticleId IdType="pubmed">28612747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Nair MG. Macrophages in wound healing: activation and plasticity. Immunol Cell Biol (2019) 97(3):258&#x2013;67. doi:&#xa0;10.1111/imcb.12236</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12236</ArticleId><ArticleId IdType="pmc">PMC6426672</ArticleId><ArticleId IdType="pubmed">30746824</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang G, Wang Y, Chi H. Regulation of TH17 cell differentiation by innate immune signals. Cell Mol Immunol (2012) 9(4):287&#x2013;95. doi:&#xa0;10.1038/cmi.2012.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2012.10</ArticleId><ArticleId IdType="pmc">PMC3423893</ArticleId><ArticleId IdType="pubmed">22504954</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmailbeig M, Ghaderi A. Interleukin-18: a regulator of cancer and autoimmune diseases. Eur Cytokine Netw (2017) 28(4):127&#x2013;40. doi:&#xa0;10.1684/ecn.2018.0401</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/ecn.2018.0401</ArticleId><ArticleId IdType="pubmed">29478963</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, et al. . Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood. (2013) 121(24):4930&#x2013;7. doi:&#xa0;10.1182/blood-2013-02-486217</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-02-486217</ArticleId><ArticleId IdType="pubmed">23645836</ArticleId></ArticleIdList></Reference><Reference><Citation>Feduska JM, Tse HM. The proinflammatory effects of macrophage-derived NADPH oxidase function in autoimmune diabetes. Free Radic Biol Med (2018) 125:81&#x2013;89. doi:&#xa0;10.1016/j.freeradbiomed.2018.04.581</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.04.581</ArticleId><ArticleId IdType="pubmed">29723665</ArticleId></ArticleIdList></Reference><Reference><Citation>Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. (1988) 27(24):8706&#x2013;11. doi:&#xa0;10.1021/bi00424a003</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00424a003</ArticleId><ArticleId IdType="pubmed">3242600</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature. (1988) 333(6174):664&#x2013;6. doi:&#xa0;10.1038/333664a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/333664a0</ArticleId><ArticleId IdType="pubmed">3131684</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath M, M&#xfc;ller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages. Front Immunol (2014) 5:532. doi:&#xa0;10.3389/fimmu.2014.00532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00532</ArticleId><ArticleId IdType="pmc">PMC4209874</ArticleId><ArticleId IdType="pubmed">25386178</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola A, Munari F, S&#xe1;nchez-Rodr&#xed;guez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol (2019) 10:1462. doi:&#xa0;10.3389/fimmu.2019.01462</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01462</ArticleId><ArticleId IdType="pmc">PMC6618143</ArticleId><ArticleId IdType="pubmed">31333642</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. . Succinate is an inflammatory signal that induces IL-1&#x3b2; through HIF-1&#x3b1;. Nature. (2013) 496(7444):238&#x2013;42. doi:&#xa0;10.1038/nature11986</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11986</ArticleId><ArticleId IdType="pmc">PMC4031686</ArticleId><ArticleId IdType="pubmed">23535595</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista-Gonzalez A, Vidal R, Criollo A, Carre&#xf1;o LJ. New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages. Front Immunol (2020) 10:2993. doi:&#xa0;10.3389/fimmu.2019.02993</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02993</ArticleId><ArticleId IdType="pmc">PMC6966486</ArticleId><ArticleId IdType="pubmed">31998297</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SC, Smith AM, Everts B, Colonna M, Pearce EL, Schilling JD, et al. . Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity. (2016) 45(4):817&#x2013;30. doi:&#xa0;10.1016/j.immuni.2016.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.09.016</ArticleId><ArticleId IdType="pmc">PMC5535820</ArticleId><ArticleId IdType="pubmed">27760338</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L, Lin L, Li Q, Liu K, Huang Y, Wang X, et al. . IGF-2 preprograms maturing macrophages to acquire oxidative phosphorylation-dependent anti-inflammatory properties. Cell Metab (2019) 29(6):1363&#x2013;75. doi:&#xa0;10.1016/j.cmet.2019.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.01.006</ArticleId><ArticleId IdType="pubmed">30745181</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas SK, Mantovani A. Orchestration of metabolism by macrophages. Cell Metab (2012) 15(4):432&#x2013;7. doi: 10.1016/j.cmet.2011.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.11.013</ArticleId><ArticleId IdType="pubmed">22482726</ArticleId></ArticleIdList></Reference><Reference><Citation>Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol (2016) 173(4):649&#x2013;65. doi:&#xa0;10.1111/bph.13139</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13139</ArticleId><ArticleId IdType="pmc">PMC4742299</ArticleId><ArticleId IdType="pubmed">25800044</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairo G, Recalcati S, Mantovani A, Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol (2011) 32(6):241&#x2013;7. doi:&#xa0;10.1016/j.it.2011.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2011.03.007</ArticleId><ArticleId IdType="pubmed">21514223</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Shi D, Li G, Jiang P. Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses. Mol Cell (2022) 82(3):527&#x2013;41. doi:&#xa0;10.1016/j.molcel.2021.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.12.006</ArticleId><ArticleId IdType="pubmed">35016033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas[J]. J Clin Invest (2012) 122(3):787&#x2013;95. doi:&#xa0;10.1172/JCI59643</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI59643</ArticleId><ArticleId IdType="pmc">PMC3287223</ArticleId><ArticleId IdType="pubmed">22378047</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray PJ. Macrophage polarization. Annu Rev Physiol (2017) 79:541&#x2013;66. doi:&#xa0;10.1146/annurev-physiol-022516-034339</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034339</ArticleId><ArticleId IdType="pubmed">27813830</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs AL, Schiller SM, Keegan WJ, Ammons MCB, Eilers B, Tripet B, et al. . Quantitative 1H NMR metabolomics reveal distinct metabolic adaptations in human macrophages following differential activation. Metabolites. (2019) 9(11):248. doi:&#xa0;10.3390/metabo9110248</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo9110248</ArticleId><ArticleId IdType="pmc">PMC6918149</ArticleId><ArticleId IdType="pubmed">31652958</ArticleId></ArticleIdList></Reference><Reference><Citation>Draijer C, Boorsma CE, Robbe P, Timens W, Hylkema MN, Ten Hacken NH, et al. . Human asthma is characterized by more IRF5+ M1 and CD206+ M2 macrophages and less IL-10+ M2-like macrophages around airways compared with healthy airways. J Allergy Clin Immunol (2017) 140(1):280&#x2013;283.e3. doi:&#xa0;10.1016/j.jaci.2016.11.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.11.020</ArticleId><ArticleId IdType="pubmed">28007476</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. (2010) 32(5):593&#x2013;604. doi:&#xa0;10.1016/j.immuni.2010.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.05.007</ArticleId><ArticleId IdType="pubmed">20510870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 23(11):549&#x2013;55. doi:&#xa0;10.1016/s1471-4906(02)02302-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1471-4906(02)02302-5</ArticleId><ArticleId IdType="pubmed">12401408</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaziz MH, Abdelwahab SF, Wan J, Cai W, Huixuan W, Jianjun C, et al. . Alternatively activated macrophages; a double-edged sword in allergic asthma. J Transl Med (2020) 18(1):58. doi:&#xa0;10.1186/s12967-020-02251-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02251-w</ArticleId><ArticleId IdType="pmc">PMC7003359</ArticleId><ArticleId IdType="pubmed">32024540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. J Leukoc Biol (2019) 106(2):345&#x2013;58. doi:&#xa0;10.1002/JLB.3RU1018-378RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3RU1018-378RR</ArticleId><ArticleId IdType="pmc">PMC7379745</ArticleId><ArticleId IdType="pubmed">30576000</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S, Dev K, Agarwal B, Das P, Syed MA. Macrophages: Their role, activation and polarization in pulmonary diseases. Immunobiology. (2018) 223(4-5):383&#x2013;96. doi:&#xa0;10.1016/j.imbio.2017.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC7114886</ArticleId><ArticleId IdType="pubmed">29146235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y. Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res (2010) 20(6):701&#x2013;12. doi:&#xa0;10.1038/cr.2010.52</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.52</ArticleId><ArticleId IdType="pubmed">20386569</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. . Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol (2018) 233(9):6425&#x2013;40. doi:&#xa0;10.1002/jcp.26429</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26429</ArticleId><ArticleId IdType="pubmed">29319160</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res (2016) 118(4):653&#x2013;67. doi:&#xa0;10.1161/CIRCRESAHA.115.306256</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306256</ArticleId><ArticleId IdType="pmc">PMC4762068</ArticleId><ArticleId IdType="pubmed">26892964</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol (2008) 180(4):2011&#x2013;7. doi:&#xa0;10.4049/jimmunol</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol</ArticleId><ArticleId IdType="pubmed">18250403</ArticleId></ArticleIdList></Reference><Reference><Citation>Funes SC, Rios M, Escobar-Vera J, Kalergis AM. Implications of macrophage polarization in autoimmunity. Immunology. (2018) 154(2):186&#x2013;95. doi:&#xa0;10.1111/imm.12910</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12910</ArticleId><ArticleId IdType="pmc">PMC5980179</ArticleId><ArticleId IdType="pubmed">29455468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. . Systemic lupus erythematosus. Nat Rev Dis Primers (2016) 2:16039. doi:&#xa0;10.1038/nrdp.2016.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Lee PY, Reeves WH. Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz). (2010) 58(5):355&#x2013;64. doi:&#xa0;10.1007/s00005-010-0093-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-010-0093-y</ArticleId><ArticleId IdType="pmc">PMC3785254</ArticleId><ArticleId IdType="pubmed">20676786</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsiari CG, Liossis SN, Sfikakis PP. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheumatol (2010) 39(6):491&#x2013;503. doi:&#xa0;10.1016/j.semarthrit.2008.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2008.11.002</ArticleId><ArticleId IdType="pubmed">19147182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma WT, Gao F, Gu K, Chen DK. The role of monocytes and macrophages in autoimmune diseases: A comprehensive review. Front Immunol (2019) 10:1140. doi:&#xa0;10.3389/fimmu.2019.01140</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01140</ArticleId><ArticleId IdType="pmc">PMC6543461</ArticleId><ArticleId IdType="pubmed">31178867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C. Macrophage depletion ameliorates nephritis induced by pathogenic antibodies. J Autoimmun (2015) 57:42&#x2013;52. doi:&#xa0;10.1016/j.jaut.2014.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2014.11.007</ArticleId><ArticleId IdType="pmc">PMC4323927</ArticleId><ArticleId IdType="pubmed">25554644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriakose J, Redecke V, Guy C, Zhou J, Wu R, Ippagunta SK, et al. . Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J Clin Invest. (2019) 129(6):2251&#x2013;65. doi:&#xa0;10.1172/JCI125116</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI125116</ArticleId><ArticleId IdType="pmc">PMC6546471</ArticleId><ArticleId IdType="pubmed">31033479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill GS, Delahousse M, Nochy D, R&#xe9;my P, Mignon F, M&#xe9;ry JP, et al. . Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int (2001) 59(1):304&#x2013;16. doi:&#xa0;10.1046/j.1523-1755.2001.00492.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2001.00492.x</ArticleId><ArticleId IdType="pubmed">11135084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto S, Nakatani K, Iwano M, Asai O, Samejima K, Sakan H, et al. . Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis (2007) 50(1):47&#x2013;58. doi:&#xa0;10.1053/j.ajkd.2007.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2007.04.012</ArticleId><ArticleId IdType="pubmed">17591524</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, et al. . Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol (2008) 180(3):1938&#x2013;47. doi:&#xa0;10.4049/jimmunol.180.3.1938</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.3.1938</ArticleId><ArticleId IdType="pmc">PMC2587994</ArticleId><ArticleId IdType="pubmed">18209092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Wu Q, Li J, Yang P, Zhu Z, Luo B, et al. . Cutting edge: defective follicular exclusion of apoptotic antigens due to marginal zone macrophage defects in autoimmune BXD2 mice. J Immunol (2013) 190(9):4465&#x2013;9. doi:&#xa0;10.4049/jimmunol.1300041</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300041</ArticleId><ArticleId IdType="pmc">PMC3656168</ArticleId><ArticleId IdType="pubmed">23543760</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev (2005) 4(4):189&#x2013;94. doi:&#xa0;10.1016/j.autrev.2004.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2004.10.007</ArticleId><ArticleId IdType="pubmed">15893710</ArticleId></ArticleIdList></Reference><Reference><Citation>Roszer T, Men&#xe9;ndez-Guti&#xe9;rrez MP, Lefterova MI, Alameda D, N&#xfa;&#xf1;ez V, Lazar MA, et al. . Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol (2011) 186(1):621&#x2013;31. doi:&#xa0;10.4049/jimmunol.1002230</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002230</ArticleId><ArticleId IdType="pmc">PMC4038038</ArticleId><ArticleId IdType="pubmed">21135166</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts AW, Lee BL, Deguine J, John S, Shlomchik MJ, Barton GM. Tissue-resident macrophages are locally programmed for silent clearance of apoptotic cells. Immunity. (2017) 47(5):913&#x2013;27. doi:&#xa0;10.1016/j.immuni.2017.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.10.006</ArticleId><ArticleId IdType="pmc">PMC5728676</ArticleId><ArticleId IdType="pubmed">29150239</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny MF, Chandaroy P, Killen PD, Caricchio R, Lewis EE, Richardson BC, et al. . Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol (2006) 176(4):2095&#x2013;104. doi:&#xa0;10.4049/jimmunol.176.4.2095</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.4.2095</ArticleId><ArticleId IdType="pubmed">16455965</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Yue Y, Dong C, Shi Y, Xiong S. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production. Clin Exp Rheumatol (2014) 32(5):705&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">25151985</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafyllopoulou A, Franzke CW, Seshan SV, Perino G, Kalliolias GD, Ramanujam M, et al. . Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A. (2010) 107(7):3012&#x2013;7. doi:&#xa0;10.1073/pnas.0914902107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914902107</ArticleId><ArticleId IdType="pmc">PMC2840310</ArticleId><ArticleId IdType="pubmed">20133703</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnblom L, Leonard D. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med (2019) 6(1):e000270. doi:&#xa0;10.1136/lupus-2018-000270</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2018-000270</ArticleId><ArticleId IdType="pmc">PMC6703304</ArticleId><ArticleId IdType="pubmed">31497305</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. Type I interferons in infectious disease. Nat Rev Immunol (2015) 15(2):87&#x2013;103. doi:&#xa0;10.1038/nri3787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson AA, Ronnblom L. Role of interferons in SLE. Best Pract Res Clin Rheumatol (2017) 31(3):415&#x2013;28. doi:&#xa0;10.1016/j.berh.2017.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2017.10.003</ArticleId><ArticleId IdType="pubmed">29224681</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumurkhuu G, Montano E, Jefferies C. Innate immune dysregulation in the development of cardiovascular disease in lupus. Curr Rheumatol Rep (2019) 21(9):46. doi:&#xa0;10.1007/s11926-019-0842-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-019-0842-9</ArticleId><ArticleId IdType="pubmed">31338604</ArticleId></ArticleIdList></Reference><Reference><Citation>Boshuizen MC, de Winther MP. Interferons as essential modulators of atherosclerosis. Arterioscler Thromb Vasc Biol (2015) 35(7):1579&#x2013;88. doi:&#xa0;10.1161/ATVBAHA.115.305464</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.115.305464</ArticleId><ArticleId IdType="pubmed">25953648</ArticleId></ArticleIdList></Reference><Reference><Citation>Crampton SP, Morawski PA, Bolland S. Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis Model Mech (2014) 7(9):1033&#x2013;46. doi:&#xa0;10.1242/dmm.016451</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.016451</ArticleId><ArticleId IdType="pmc">PMC4142724</ArticleId><ArticleId IdType="pubmed">25147296</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Fu YX, Wu Q, Zhou Y, Crossman DK, Yang P, et al. . Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus. J Clin Invest. (2015) 125(7):2877&#x2013;90. doi:&#xa0;10.1172/JCI81059</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81059</ArticleId><ArticleId IdType="pmc">PMC4563689</ArticleId><ArticleId IdType="pubmed">26098211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JH, Li J, Wu Q, Yang P, Pawar RD, Xie S, et al. . Marginal zone precursor b cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity. J Immunol (2010) 184(1):442&#x2013;51. doi:&#xa0;10.4049/jimmunol.0900870</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0900870</ArticleId><ArticleId IdType="pmc">PMC2830207</ArticleId><ArticleId IdType="pubmed">19949066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Ortiz ZG, Prasad A, Griffith JW, Pendergraft WF, 3rd, Cowley GS, Root DE, et al. . The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity. Nat Immunol (2015) 16(5):495&#x2013;504. doi:&#xa0;10.1038/ni.3143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3143</ArticleId><ArticleId IdType="pmc">PMC4406861</ArticleId><ArticleId IdType="pubmed">25848864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Wu R, High AA, Slaughter CA, Finkelstein D, Rehg JE, et al. . A20-binding inhibitor of NF-&#x3ba;B (ABIN1) controls toll-like receptor-mediated CCAAT/enhancer-binding protein &#x3b2; activation and protects from inflammatory disease. Proc Natl Acad Sci U S A. (2011) 108(44):E998&#x2013;1006. doi:&#xa0;10.1073/pnas.1106232108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1106232108</ArticleId><ArticleId IdType="pmc">PMC3207663</ArticleId><ArticleId IdType="pubmed">22011580</ArticleId></ArticleIdList></Reference><Reference><Citation>Orme J, Mohan C. Macrophages and neutrophils in SLE-an online molecular catalog. Autoimmun Rev (2012) 11(5):365&#x2013;72. doi:&#xa0;10.1016/j.autrev.2011.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.10.010</ArticleId><ArticleId IdType="pubmed">22036828</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp&#xed;n JC, Hedrich CM, Tsokos GC. Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol (2013) 9(8):476&#x2013;84. doi:&#xa0;10.1038/nrrheum.2013.78</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2013.78</ArticleId><ArticleId IdType="pubmed">23732569</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaper F, de Leeuw K, Horst G, Bootsma H, Limburg PC, Heeringa P, et al. . High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells. Rheumatol (Oxford). (2016) 55(12):2260&#x2013;70. doi:&#xa0;10.1093/rheumatology/kew324</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew324</ArticleId><ArticleId IdType="pubmed">27632996</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn J, Euler M, Kilgus E, Kienh&#xf6;fer D, Stoof J, Knopf J, et al. . NOX2 mediates quiescent handling of dead cell remnants in phagocytes. Redox Biol (2019) 26:101279. doi:&#xa0;10.1016/j.redox.2019.101279</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101279</ArticleId><ArticleId IdType="pmc">PMC6669319</ArticleId><ArticleId IdType="pubmed">31349119</ArticleId></ArticleIdList></Reference><Reference><Citation>Labonte AC, Kegerreis B, Geraci NS, Bachali P, Madamanchi S, Robl R, et al. . Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus. PloS One (2018) 13(12):e0208132. doi:&#xa0;10.1371/journal.pone.0208132</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208132</ArticleId><ArticleId IdType="pmc">PMC6298676</ArticleId><ArticleId IdType="pubmed">30562343</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata Y, Bostr&#xf6;m EA, Menke J, Rabacal WA, Morel L, Wada T, et al. . Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice. J Immunol (2012) 188(9):4568&#x2013;80. doi:&#xa0;10.4049/jimmunol.1102154</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102154</ArticleId><ArticleId IdType="pmc">PMC3340928</ArticleId><ArticleId IdType="pubmed">22467656</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. (2006) 129(6):1673&#x2013;82. doi:&#xa0;10.1378/chest.129.6.1673</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.129.6.1673</ArticleId><ArticleId IdType="pubmed">16778289</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol (2014) 14(3):166&#x2013;80. doi:&#xa0;10.1038/nri3607</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3607</ArticleId><ArticleId IdType="pmc">PMC4040260</ArticleId><ArticleId IdType="pubmed">24481336</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi S, Saghaeian-Jazi M, Sedighi S, Memarian A. Immunomodulation in systemic lupus erythematosus: induction of M2 population in monocyte-derived macrophages by pioglitazone. Lupus. (2017) 26(12):1318&#x2013;27. doi:&#xa0;10.1177/0961203317701842</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317701842</ArticleId><ArticleId IdType="pubmed">28457196</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Zhu X, Yang Y, Huang L, Xu J. TIPE2 alleviates systemic lupus erythematosus through regulating macrophage polarization. Cell Physiol Biochem (2016) 38(1):330&#x2013;9. doi:&#xa0;10.1159/000438633</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000438633</ArticleId><ArticleId IdType="pubmed">26824452</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Yang Y, Zhu X, Huang L, Xu J. Macrophage polarization modulates development of systemic lupus erythematosus. Cell Physiol Biochem (2015) 37(4):1279&#x2013;88. doi:&#xa0;10.1159/000430251</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000430251</ArticleId><ArticleId IdType="pubmed">26431544</ArticleId></ArticleIdList></Reference><Reference><Citation>Horuluoglu B, Bayik D, Kayraklioglu N, Goguet E, Kaplan MJ, Klinman DM. PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus. J Autoimmun (2019) 99:24&#x2013;32. doi:&#xa0;10.1016/j.jaut.2019.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.01.004</ArticleId><ArticleId IdType="pmc">PMC6462249</ArticleId><ArticleId IdType="pubmed">30679006</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparicio-Soto M, Montserrat-de la Paz S, Sanchez-Hidalgo M, Cardeno A, Bermudez B, Muriana FJG, et al. . Virgin olive oil and its phenol fraction modulate monocyte/macrophage functionality: a potential therapeutic strategy in the treatment of systemic lupus erythematosus. Br J Nutr (2018) 120(6):681&#x2013;92. doi:&#xa0;10.1017/S0007114518001976</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114518001976</ArticleId><ArticleId IdType="pubmed">30060774</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparicio-Soto M, S&#xe1;nchez-Hidalgo M, Alarc&#xf3;n-de-la-Lastra C. An update on diet and nutritional factors in systemic lupus erythematosus management. Nutr Res Rev (2017) 30(1):118&#x2013;37. doi:&#xa0;10.1017/S0954422417000026</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0954422417000026</ArticleId><ArticleId IdType="pubmed">28294088</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus (2005) 14 Suppl 1:s2&#x2013;8. doi:&#xa0;10.1191/0961203305lu2109oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203305lu2109oa</ArticleId><ArticleId IdType="pubmed">15803924</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon BR, Yoo SJ, Choi Yh, Chung YH, Kim J, Yoo IS, et al. . Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA). PloS One (2014) 9(10):e109775. doi:&#xa0;10.1371/journal.pone.0109775</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0109775</ArticleId><ArticleId IdType="pmc">PMC4201467</ArticleId><ArticleId IdType="pubmed">25329467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis (1994) 53(1):39&#x2013;44. doi:&#xa0;10.1136/ard.53.1.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.53.1.39</ArticleId><ArticleId IdType="pmc">PMC1005241</ArticleId><ArticleId IdType="pubmed">8311554</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson AM, Schmutz C, Davis S, Gardner L, Ashton BA, Middleton J. Differential binding of chemokines to macrophages and neutrophils in the human inflamed synovium. Arthritis Res (2002) 4(3):209&#x2013;14. doi:&#xa0;10.1186/ar408</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar408</ArticleId><ArticleId IdType="pmc">PMC111024</ArticleId><ArticleId IdType="pubmed">12010572</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards PJ, Williams AS, Goodfellow RM, Williams BD. Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis. Rheumatol (Oxford). (1999) 38(9):818&#x2013;25. doi:&#xa0;10.1093/rheumatology/38.9.818</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/38.9.818</ArticleId><ArticleId IdType="pubmed">10515641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton JA, Tak PP. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheumatol (2009) 60(5):1210&#x2013;21. doi:&#xa0;10.1002/art.24505</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24505</ArticleId><ArticleId IdType="pubmed">19404968</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QQ, Birkett R, Doyle R, Shi B, Roberts EL, Mao Q, et al. . The role of macrophages in the response to TNF inhibition in experimental arthritis. J Immunol (2018) 200(1):130&#x2013;8. doi:&#xa0;10.4049/jimmunol.1700229</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700229</ArticleId><ArticleId IdType="pmc">PMC5736443</ArticleId><ArticleId IdType="pubmed">29150565</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutet MA, Courties G, Nerviani A, Le Goff B, Apparailly F, Pitzalis C, et al. . Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmun Rev (2021) 20(3):102758. doi:&#xa0;10.1016/j.autrev.2021.102758</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102758</ArticleId><ArticleId IdType="pubmed">33476818</ArticleId></ArticleIdList></Reference><Reference><Citation>Corvaisier M, Delneste Y, Jeanvoine H, Preisser L, Blanchard S, Garo E, et al. . IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PloS Biol (2012) 10(9):e1001395. doi:&#xa0;10.1371/journal.pbio.1001395</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001395</ArticleId><ArticleId IdType="pmc">PMC3463509</ArticleId><ArticleId IdType="pubmed">23055831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KA, Kim KW, Kim BM, Won JY, Min HK, Lee DW, et al. . Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. Arthritis Res Ther (2019) 21(1):283. doi:&#xa0;10.1186/s13075-019-2070-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-2070-0</ArticleId><ArticleId IdType="pmc">PMC6909469</ArticleId><ArticleId IdType="pubmed">31831038</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabiec AM, Krausz S, de Jager W, Burakowski T, Groot D, Sanders ME, et al. . Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol (2010) 184(5):2718&#x2013;28. doi:&#xa0;10.4049/jimmunol.0901467</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901467</ArticleId><ArticleId IdType="pubmed">20100935</ArticleId></ArticleIdList></Reference><Reference><Citation>Semerano L, Clavel G, Assier E, Denys A, Boissier MC. Blood vessels, a potential therapeutic target in rheumatoid arthritis? Joint Bone Spine (2011) 78(2):118&#x2013;23. doi:&#xa0;10.1016/j.jbspin.2010.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2010.06.004</ArticleId><ArticleId IdType="pubmed">20851025</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. . Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. (1992) 258(5089):1798&#x2013;801. doi:&#xa0;10.1126/science.1281554</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1281554</ArticleId><ArticleId IdType="pubmed">1281554</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbano C, Villar-Vesga J, V&#xe1;squez G, Mu&#xf1;oz-Vahos C, Rojas M, Casta&#xf1;o D. Proinflammatory differentiation of macrophages through microparticles that form immune complexes leads to T- and b-cell activation in systemic autoimmune diseases. Front Immunol (2019) 10:2058. doi:&#xa0;10.3389/fimmu.2019.02058</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02058</ArticleId><ArticleId IdType="pmc">PMC6724570</ArticleId><ArticleId IdType="pubmed">31555283</ArticleId></ArticleIdList></Reference><Reference><Citation>Smiljanovic B, Gr&#xfc;tzkau A, S&#xf6;rensen T, Gr&#xfc;n JR, Vogl T, Bonin M, et al. . Synovial tissue transcriptomes of long-standing rheumatoid arthritis are dominated by activated macrophages that reflect microbial stimulation. Sci Rep (2020) 10(1):7907. doi:&#xa0;10.1038/s41598-020-64431-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64431-4</ArticleId><ArticleId IdType="pmc">PMC7220941</ArticleId><ArticleId IdType="pubmed">32404914</ArticleId></ArticleIdList></Reference><Reference><Citation>Degbo&#xe9; Y, Rauwel B, Baron M, Boyer JF, Ruyssen-Witrand A, Constantin A, et al. . Polarization of rheumatoid macrophages by TNF targeting through an IL-10/STAT3 mechanism. Front Immunol (2019) 10:3. doi:&#xa0;10.3389/fimmu.2019.00003</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00003</ArticleId><ArticleId IdType="pmc">PMC6345709</ArticleId><ArticleId IdType="pubmed">30713533</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotti C, Biggioggero M, Becciolini A, Agape E, Favalli EG. Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis. Expert Opin Investig Drugs (2019) 28(7):573&#x2013;81. doi:&#xa0;10.1080/13543784.2019.1631795</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2019.1631795</ArticleId><ArticleId IdType="pubmed">31208237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen JH, Guo X, De Los Reyes M, Dziegiel MH, Karsdal MA, Bay-Jensen AC, et al. . The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR&#x3b1;-mAb treatment in rheumatoid arthritis patients. Clin Exp Rheumatol (2019) 37(1):73&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">30418117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Wang B, Shen J, Low SA, Putt KS, Niessen HWM, et al. . Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis. Arthritis Res Ther (2019) 21(1):143. doi:&#xa0;10.1186/s13075-019-1912-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1912-0</ArticleId><ArticleId IdType="pmc">PMC6555977</ArticleId><ArticleId IdType="pubmed">31174578</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoletti A, Rohmer J, Ly B, Pascaud J, Rivi&#xe8;re E, Seror R, et al. . Monocyte/Macrophage abnormalities specific to rheumatoid arthritis are linked to miR-155 and are differentially modulated by different TNF inhibitors. J Immunol (2019) 203(7):1766&#x2013;75. doi:&#xa0;10.4049/jimmunol.1900386</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900386</ArticleId><ArticleId IdType="pmc">PMC6755128</ArticleId><ArticleId IdType="pubmed">31484730</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler Palacios B, Estrada-Capetillo L, Izquierdo E, Criado G, Nieto C, Municio C, et al. . Macrophages from the synovium of active rheumatoid arthritis exhibit an activin a-dependent pro-inflammatory profile. J Pathol (2015) 235(3):515&#x2013;26. doi:&#xa0;10.1002/path.4466</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4466</ArticleId><ArticleId IdType="pubmed">25319955</ArticleId></ArticleIdList></Reference><Reference><Citation>Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: Different gene signatures in M1(LPS+) vs. Classically M2(LPS-) vs. Alternatively Activated Macrophages. Front Immunol (2019) 10:1084. doi:&#xa0;10.3389/fimmu.2019.01084</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01084</ArticleId><ArticleId IdType="pmc">PMC6543837</ArticleId><ArticleId IdType="pubmed">31178859</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Chang Y, Wei W. Emerging role of targeting macrophages in rheumatoid arthritis: Focus on polarization, metabolism and apoptosis. Cell Prolif. (2020) 53(7):e12854. doi:&#xa0;10.1111/cpr.12854</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12854</ArticleId><ArticleId IdType="pmc">PMC7377929</ArticleId><ArticleId IdType="pubmed">32530555</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G, Lu Q, Fan H, Zhang X, Ge L, Tian R, et al. . Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis. Arthritis Res Ther (2019) 21(1):87. doi:&#xa0;10.1186/s13075-019-1865-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1865-3</ArticleId><ArticleId IdType="pmc">PMC6446273</ArticleId><ArticleId IdType="pubmed">30944034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Liu J, Huang C, Tao Y, Wang Y, Chen X, et al. . Wilforlide a ameliorates the progression of rheumatoid arthritis by inhibiting M1 macrophage polarization. J Pharmacol Sci (2022) 148(1):116&#x2013;24. doi:&#xa0;10.1016/j.jphs.2021.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphs.2021.10.005</ArticleId><ArticleId IdType="pubmed">34924115</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Tu J, Jiang J, Zhang Q, Liu Q, K&#xf6;rner H, et al. . Angiotensin II type 2 receptor modulates synovial macrophage polarization by inhibiting GRK2 membrane translocation in a rat model of collagen-induced arthritis. J Immunol (2020) 205(11):3141&#x2013;53. doi:&#xa0;10.4049/jimmunol.2000561</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000561</ArticleId><ArticleId IdType="pubmed">33148713</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Kwon S, Kim SH, Kang YJ, Khang D. Triamcinolone-gold nanoparticles repolarize synoviocytes and macrophages in an inflamed synovium. ACS Appl Mater Interfaces. (2020) 12(35):38936&#x2013;49. doi:&#xa0;10.1021/acsami.0c09842</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.0c09842</ArticleId><ArticleId IdType="pubmed">32805872</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, et al. . M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. J Control Release. (2022) 341:16&#x2013;30. doi:&#xa0;10.1016/j.jconrel.2021.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2021.11.019</ArticleId><ArticleId IdType="pubmed">34793917</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo RB, Zhang XY, Yan DK, Yu YJ, Wang YJ, Geng HX, et al. . Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy. Biomater Sci (2022) 10(2):499&#x2013;513. doi:&#xa0;10.1039/d1bm01520f</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d1bm01520f</ArticleId><ArticleId IdType="pubmed">34904598</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Guo L, Wang Z, Liu P, Liu X, Ding J, et al. . Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials. (2021) 264:120390. doi:&#xa0;10.1016/j.biomaterials.2020.120390</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2020.120390</ArticleId><ArticleId IdType="pubmed">32980634</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Front Immunol (2015) 6:272. doi:&#xa0;10.3389/fimmu.2015.00272</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00272</ArticleId><ArticleId IdType="pmc">PMC4459100</ArticleId><ArticleId IdType="pubmed">26106387</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M, O'Reilly S. The immunopathogenesis of fibrosis in systemic sclerosis. Clin Exp Immunol (2019) 195(3):310&#x2013;21. doi:&#xa0;10.1111/cei.13238</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13238</ArticleId><ArticleId IdType="pmc">PMC6378383</ArticleId><ArticleId IdType="pubmed">30430560</ArticleId></ArticleIdList></Reference><Reference><Citation>LeRoy EC. Systemic sclerosis. a vascular perspective. Rheum Dis Clin North Am (1996) 22(4):675&#x2013;94. doi:&#xa0;10.1016/s0889-857x(05)70295-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0889-857x(05)70295-7</ArticleId><ArticleId IdType="pubmed">8923590</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiducci S, Giacomelli R, Cerinic MM. Vascular complications of scleroderma. Autoimmun Rev (2007) 6(8):520&#x2013;3. doi:&#xa0;10.1016/j.autrev.2006.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2006.12.006</ArticleId><ArticleId IdType="pubmed">17854742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;ling BM, Maul GG, Jimenez SA. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology. (1995) 63(1):48&#x2013;56. doi:&#xa0;10.1159/000163933</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000163933</ArticleId><ArticleId IdType="pubmed">7546275</ArticleId></ArticleIdList></Reference><Reference><Citation>Misharin AV, Morales-Nebreda L, Reyfman PA, Cuda CM, Walter JM, McQuattie-Pimentel AC, et al. . Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med (2017) 214(8):2387&#x2013;404. doi:&#xa0;10.1084/jem.20162152</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20162152</ArticleId><ArticleId IdType="pmc">PMC5551573</ArticleId><ArticleId IdType="pubmed">28694385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballerie A, Lescoat A, Augagneur Y, Lelong M, Morzadec C, Cazalets C, et al. . Efferocytosis capacities of blood monocyte-derived macrophages in systemic sclerosis. Immunol Cell Biol (2019) 97(3):340&#x2013;7. doi:&#xa0;10.1111/imcb.12217</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12217</ArticleId><ArticleId IdType="pubmed">30426551</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnik M, Hukara A, Kocherova I, Jordan S, Schniering J, Milleret V, et al. . Elevated fibronectin levels in profibrotic CD14+ monocytes and CD14+ macrophages in systemic sclerosis. Front Immunol (2021) 12:642891. doi:&#xa0;10.3389/fimmu.2021.642891</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.642891</ArticleId><ArticleId IdType="pmc">PMC8421541</ArticleId><ArticleId IdType="pubmed">34504485</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R. Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev (2011) 10(10):590&#x2013;4. doi:&#xa0;10.1016/j.autrev.2011.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.04.019</ArticleId><ArticleId IdType="pubmed">21549861</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent P, Lapoirie J, Leleu D, Levionnois E, Grenier C, Jurado-Mestre B, et al. . F&#xe9;d&#xe9;ration hospitalo-universitaire ACRONIM and the centre national de r&#xe9;f&#xe9;rence des maladies auto-immunes syst&#xe9;miques rares de l'Est et du sud-ouest (RESO). interleukin-1&#x3b2;-Activated microvascular endothelial cells promote DC-SIGN-Positive alternatively activated macrophages as a mechanism of skin fibrosis in systemic sclerosis. Arthritis Rheumatol (2022) 74(6):1013&#x2013;26. doi:&#xa0;10.1002/art.42061</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42061</ArticleId><ArticleId IdType="pubmed">34962361</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi T, Miyagawa T, Toyama S, Yamashita T, Nakamura K, Saigusa R, et al. . CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis. Exp Dermatol (2018) 27(9):1030&#x2013;7. doi:&#xa0;10.1111/exd.13724</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.13724</ArticleId><ArticleId IdType="pubmed">29947047</ArticleId></ArticleIdList></Reference><Reference><Citation>Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, et al. . Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res (2004) 95(1):109&#x2013;16. doi:&#xa0;10.1161/01.RES.0000134644.89917.96</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000134644.89917.96</ArticleId><ArticleId IdType="pubmed">15178641</ArticleId></ArticleIdList></Reference><Reference><Citation>Numajiri H, Kuzumi A, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Asano Y, et al. . B cell depletion inhibits fibrosis via suppression of profibrotic macrophage differentiation in a mouse model of systemic sclerosis. Arthritis Rheumatol (2021) 73(11):2086&#x2013;95. doi:&#xa0;10.1002/art.41798</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41798</ArticleId><ArticleId IdType="pubmed">33955200</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo DM, Pioli PA. Macrophages in systemic sclerosis: Novel insights and therapeutic implications. Curr Rheumatol Rep (2019) 21(7):31. doi:&#xa0;10.1007/s11926-019-0831-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-019-0831-z</ArticleId><ArticleId IdType="pmc">PMC7444604</ArticleId><ArticleId IdType="pubmed">31123840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescoat A, Ballerie A, Lelong M, Augagneur Y, Morzadec C, Jouneau S, et al. . Crystalline silica impairs efferocytosis abilities of human and mouse macrophages: Implication for silica-associated systemic sclerosis. Front Immunol (2020) 11:219. doi:&#xa0;10.3389/fimmu.2020.00219</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00219</ArticleId><ArticleId IdType="pmc">PMC7039938</ArticleId><ArticleId IdType="pubmed">32133004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Chen SY. RGC32 promotes bleomycin-induced systemic sclerosis in a murine disease model by modulating classically activated macrophage function. J Immunol (2018) 200(8):2777&#x2013;85. doi:&#xa0;10.4049/jimmunol.1701542</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701542</ArticleId><ArticleId IdType="pmc">PMC5893351</ArticleId><ArticleId IdType="pubmed">29507108</ArticleId></ArticleIdList></Reference><Reference><Citation>Taroni JN, Greene CS, Martyanov V, Wood TA, Christmann RB, Farber HW, et al. . A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis. Genome Med (2017) 9(1):27. doi:&#xa0;10.1186/s13073-017-0417-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-017-0417-1</ArticleId><ArticleId IdType="pmc">PMC5363043</ArticleId><ArticleId IdType="pubmed">28330499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Yan S, Yang C, Yang J, Wang H, Li C, et al. . Mesenchymal stem cells-derived exosomes ameliorate lupus by inducing M2 macrophage polarization and regulatory T cell expansion in MRL/lpr mice. Immunol Invest. (2022) 51(6):1785&#x2013;803. doi:&#xa0;10.1080/08820139.2022.2055478</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820139.2022.2055478</ArticleId><ArticleId IdType="pubmed">35332841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bielecki M, Kowal K, Lapinska A, Chyczewski L, Kowal-Bielecka O. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis. Adv Med Sci (2013) 58(1):126&#x2013;33. doi:&#xa0;10.2478/v10039-012-0076-9</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/v10039-012-0076-9</ArticleId><ArticleId IdType="pubmed">23640944</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi-Kuwata N, Makino T, Inoue Y, Takeya M, Ihn H. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma. Exp Dermatol (2009) 18(8):727&#x2013;9. doi:&#xa0;10.1111/j.1600-0625.2008.00828.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0625.2008.00828.x</ArticleId><ArticleId IdType="pubmed">19320738</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Ramming A, Bergmann C, Weinkam R, Kittan N, Schett G, et al. . Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages. Ann Rheum Dis (2017) 76(6):1133&#x2013;41. doi:&#xa0;10.1136/annrheumdis-2016-210189</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-210189</ArticleId><ArticleId IdType="pubmed">28209630</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Asano Y, Taniguchi T, Nakamura K, Saigusa R, Miura S, et al. . Glycyrrhizin ameliorates fibrosis, vasculopathy, and inflammation in animal models of systemic sclerosis. J Invest Dermatol (2017) 137(3):631&#x2013;40. doi:&#xa0;10.1016/j.jid.2016.08.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2016.08.037</ArticleId><ArticleId IdType="pmc">PMC5380226</ArticleId><ArticleId IdType="pubmed">27777101</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Maier C, Zhang Y, Soare A, Dees C, Beyer C, et al. . Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis. Ann Rheum Dis (2017) 76(11):1941&#x2013;8. doi:&#xa0;10.1136/annrheumdis-2016-210823</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-210823</ArticleId><ArticleId IdType="pubmed">28814429</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TM, Steen VD, et al. . Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis (2020) 79(3):379&#x2013;86. doi:&#xa0;10.1136/annrheumdis-2019-215894</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215894</ArticleId><ArticleId IdType="pmc">PMC7386329</ArticleId><ArticleId IdType="pubmed">31767698</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent P, Sisirak V, Lazaro E, Richez C, Duffau P, Blanco P, et al. . Innate immunity in systemic sclerosis fibrosis: Recent advances. Front Immunol (2018) 9:1702. doi:&#xa0;10.3389/fimmu.2018.01702</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01702</ArticleId><ArticleId IdType="pmc">PMC6064727</ArticleId><ArticleId IdType="pubmed">30083163</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeljeli M, Riccio LGC, Doridot L, Ch&#xea;ne C, Nicco C, Chouzenoux S, et al. . Trained immunity modulates inflammation-induced fibrosis. Nat Commun (2019) 10(1):5670. doi:&#xa0;10.1038/s41467-019-13636-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13636-x</ArticleId><ArticleId IdType="pmc">PMC6906311</ArticleId><ArticleId IdType="pubmed">31827093</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol (2005) 23:447&#x2013;85. doi:&#xa0;10.1146/annurev.immunol</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol</ArticleId><ArticleId IdType="pubmed">15771578</ArticleId></ArticleIdList></Reference><Reference><Citation>Burg AR, Tse HM. Redox-sensitive innate immune pathways during macrophage activation in type 1 diabetes. Antioxid Redox Signal (2018) 29(14):1373&#x2013;98. doi:&#xa0;10.1089/ars.2017.7243</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7243</ArticleId><ArticleId IdType="pmc">PMC6166692</ArticleId><ArticleId IdType="pubmed">29037052</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Reilly LA, Hutchings PR, Crocker PR, Simpson E, Lund T, Kioussis D, et al. . Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol (1991) 21(5):1171&#x2013;80. doi:&#xa0;10.1002/eji.1830210512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830210512</ArticleId><ArticleId IdType="pubmed">1674689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia. (1989) 32(2):126&#x2013;34. doi:&#xa0;10.1007/BF00505185</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00505185</ArticleId><ArticleId IdType="pubmed">2656351</ArticleId></ArticleIdList></Reference><Reference><Citation>Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol (2009) 155(2):173&#x2013;81. doi:&#xa0;10.1111/j.1365-2249.2008.03860.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2008.03860.x</ArticleId><ArticleId IdType="pmc">PMC2675247</ArticleId><ArticleId IdType="pubmed">19128359</ArticleId></ArticleIdList></Reference><Reference><Citation>Oschilewski U, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB-rats. Diabetes (1985) 34(2):197&#x2013;9. doi:&#xa0;10.2337/diab.34.2.197</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.34.2.197</ArticleId><ArticleId IdType="pubmed">2981751</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb H, Burkart V, Appels B, Hanenberg H, Kantwerk-Funke G, Kiesel U, et al. . Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J Autoimmun (1990) 3 Suppl 1:117&#x2013;20. doi:&#xa0;10.1016/s0896-8411(09)90020-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-8411(09)90020-8</ArticleId><ArticleId IdType="pubmed">2140261</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun HS, Santamaria P, Lim HW, Zhang ML, Yoon JW. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes. (1999) 48(1):34&#x2013;42. doi:&#xa0;10.2337/diabetes.48.1.34</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.48.1.34</ArticleId><ArticleId IdType="pubmed">9892220</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderon B, Suri A, Unanue ER. In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model. Am J Pathol (2006) 169(6):2137&#x2013;47. doi:&#xa0;10.2353/ajpath.2006.060539</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2006.060539</ArticleId><ArticleId IdType="pmc">PMC1762478</ArticleId><ArticleId IdType="pubmed">17148676</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornley TB, Agarwal KA, Kyriazis P, Ma L, Chipashvili V, Aker JE, et al. . Contrasting roles of islet resident immunoregulatory macrophages and dendritic cells in experimental autoimmune type 1 diabetes. PloS One (2016) 11(3):e0150792. doi:&#xa0;10.1371/journal.pone.0150792</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150792</ArticleId><ArticleId IdType="pmc">PMC4778921</ArticleId><ArticleId IdType="pubmed">26943809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Tan SB, Guo ZG. CD47 decline in pancreatic islet cells promotes macrophage-mediated phagocytosis in type I diabetes. World J Diabetes. (2020) 11(6):239&#x2013;51. doi:&#xa0;10.4239/wjd.v11.i6.239</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v11.i6.239</ArticleId><ArticleId IdType="pmc">PMC7284019</ArticleId><ArticleId IdType="pubmed">32547698</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor J, Haskins K. Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1. J Immunol (2007) 179(9):5760&#x2013;7. doi:&#xa0;10.4049/jimmunol.179.9.5760</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.9.5760</ArticleId><ArticleId IdType="pubmed">17947648</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoffels K, Overbergh L, Giulietti A, Kasran A, Bouillon R, Gysemans C, et al. . NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. J Autoimmun (2004) 23(1):9&#x2013;15. doi:&#xa0;10.1016/j.jaut.2004.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2004.03.012</ArticleId><ArticleId IdType="pubmed">15236748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xe9;e AF, Kublik R, Finegood DT, Edelstein-Keshet L. Modelling the onset of type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease? Philos Trans A Math Phys Eng Sci (2006) 364(1842). doi:&#xa0;10.1098/rsta.2006.1769</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2006.1769</ArticleId><ArticleId IdType="pubmed">16608707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YH, Jun HS, Kang Y, Hirasawa K, Lee BR, Van Rooijen N, et al. . Role of macrophages and macrophage-derived cytokines in the pathogenesis of kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J Immunol (1997) 159(1):466&#x2013;71. doi: 10.4049/jimmunol.159.1.466</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.159.1.466</ArticleId><ArticleId IdType="pubmed">9200487</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana J, Lehuen A. Macrophages and &#x3b2;-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes. EMBO Mol Med (2014) 6(8):1090&#x2013;104. doi:&#xa0;10.15252/emmm.201404144</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404144</ArticleId><ArticleId IdType="pmc">PMC4154135</ArticleId><ArticleId IdType="pubmed">24968718</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest. (2000) 105(4):459&#x2013;68. doi:&#xa0;10.1172/JCI8185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI8185</ArticleId><ArticleId IdType="pmc">PMC289158</ArticleId><ArticleId IdType="pubmed">10683375</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med (1999) 189(2):347&#x2013;58. doi:&#xa0;10.1084/jem.189.2.347</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.189.2.347</ArticleId><ArticleId IdType="pmc">PMC2192977</ArticleId><ArticleId IdType="pubmed">9892617</ArticleId></ArticleIdList></Reference><Reference><Citation>Marro BS, Legrain S, Ware BC, Oldstone MB. Macrophage IFN-I signaling promotes autoreactive T cell infiltration into islets in type 1 diabetes model. JCI Insight (2019) 4(2):e125067. doi:&#xa0;10.1172/jci.insight.125067</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.125067</ArticleId><ArticleId IdType="pmc">PMC6413832</ArticleId><ArticleId IdType="pubmed">30674713</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsa R, Andresen P, Gillett A, Mia S, Zhang XM, Mayans S, et al. . Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes. (2012) 61(11):2881&#x2013;92. doi:&#xa0;10.2337/db11-1635</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-1635</ArticleId><ArticleId IdType="pmc">PMC3478537</ArticleId><ArticleId IdType="pubmed">22745325</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ding X, Tian X, Zheng J, Ding C, Li X, et al. . Islet transplantation modulates macrophage to induce immune tolerance and angiogenesis of islet tissue in type I diabetes mice model. Aging (Albany NY). (2020) 12(23):24023&#x2013;32. doi:&#xa0;10.18632/aging.104085</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.104085</ArticleId><ArticleId IdType="pmc">PMC7762494</ArticleId><ArticleId IdType="pubmed">33221752</ArticleId></ArticleIdList></Reference><Reference><Citation>Barra JM, Kozlovskaya V, Kharlampieva E, Tse HM. Localized immunosuppression with tannic acid encapsulation delays islet allograft and autoimmune-mediated rejection. Diabetes. (2020) 69(9):1948&#x2013;60. doi:&#xa0;10.2337/db20-0248</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db20-0248</ArticleId><ArticleId IdType="pmc">PMC7458038</ArticleId><ArticleId IdType="pubmed">32586979</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Nagy T, Guo TL. Glycated whey proteins protect NOD mice against type 1 diabetes by increasing anti-inflammatory responses and decreasing autoreactivity to self-antigens. J Funct Foods. (2019) 56:171&#x2013;81. doi:&#xa0;10.1016/j.jff.2019.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2019.03.015</ArticleId><ArticleId IdType="pmc">PMC6907084</ArticleId><ArticleId IdType="pubmed">31832103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Sun F, Luo J, Yue T, Chen L, Zhou H, et al. . Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization. Cell Death Dis (2019) 10(12):892. doi:&#xa0;10.1038/s41419-019-2130-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-2130-z</ArticleId><ArticleId IdType="pmc">PMC6877645</ArticleId><ArticleId IdType="pubmed">31767832</ArticleId></ArticleIdList></Reference><Reference><Citation>Timper K, Hruz P, Beglinger C, Donath MY. Infliximab in the treatment of crohn disease and type 1 diabetes. Diabetes Care (2013) 36(7):e90&#x2013;1. doi:&#xa0;10.2337/dc13-0199</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-0199</ArticleId><ArticleId IdType="pmc">PMC3687309</ArticleId><ArticleId IdType="pubmed">23801815</ArticleId></ArticleIdList></Reference><Reference><Citation>Green EA, Flavell RA. Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice. Immunol Rev (1999) 169:11&#x2013;22. doi:&#xa0;10.1111/j.1600-065x.1999.tb01302.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065x.1999.tb01302.x</ArticleId><ArticleId IdType="pubmed">10450504</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Scholten BJ, Kreiner FF, Gough SCL, von Herrath M. Current and future therapies for type 1 diabetes. Diabetologia. (2021) 64(5):1037&#x2013;48. doi:&#xa0;10.1007/s00125-021-05398-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-021-05398-3</ArticleId><ArticleId IdType="pmc">PMC8012324</ArticleId><ArticleId IdType="pubmed">33595677</ArticleId></ArticleIdList></Reference><Reference><Citation>Citro A, Cantarelli E, Piemonti L. The CXCR1/2 pathway: Involvement in diabetes pathophysiology and potential target for T1D interventions. Curr Diabetes Rep (2015) 15(10):68. doi:&#xa0;10.1007/s11892-015-0638-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-015-0638-x</ArticleId><ArticleId IdType="pubmed">26275440</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, He Y, Zhu Y, Jiang L, Zhang S, Qin J, et al. . Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano Lett (2019) 19(1):124&#x2013;34. doi:&#xa0;10.1021/acs.nanolett.8b03439</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.8b03439</ArticleId><ArticleId IdType="pubmed">30521345</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang TT, Lv LL, Wang B, Cao JY, Feng Y, Li ZL, et al. . Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: An efficient therapeutic strategy against renal inflammation and fibrosis. Theranostics. (2019) 9(16):4740&#x2013;55. doi:&#xa0;10.7150/thno.33520</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.33520</ArticleId><ArticleId IdType="pmc">PMC6643445</ArticleId><ArticleId IdType="pubmed">31367254</ArticleId></ArticleIdList></Reference><Reference><Citation>Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. . Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol (2019) 20(2):163&#x2013;72. doi:&#xa0;10.1038/s41590-018-0276-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0276-y</ArticleId><ArticleId IdType="pmc">PMC6340744</ArticleId><ArticleId IdType="pubmed">30643263</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>